the Effect of Transcutaneous Electrical Acupoint Stimulation on the Quality of Oocyte on Poor Ovarian Response(POR)
- Conditions
- Poor Ovarian Response
- Interventions
- Other: TEAS
- Registration Number
- NCT03994614
- Lead Sponsor
- ShangHai Ji Ai Genetics & IVF Institute
- Brief Summary
Patients in experimental group will be given transcutaneous electrical acupoint stimulation (TEAS) treatment for 12 weeks prior to controlled ovarian stimulation (COS).The patients will be given three times acupuncture every week except menstruation.Patients in no intervention group will not be given any interventions for 12 weeks prior to COS. The primary outcome measure is the number of MII eggs obtained in the COS cycle. The secondary outcome measures are the lab and clinical reproductive outcomes.
- Detailed Description
The patients will be randomly recruited into two groups. Patients in experimental group will be given TEAS treatment for 12 weeks prior to COS.The patients will be given three times acupuncture every week except menstruation. One treatment lasts for 30 minutes. The acupoints used for the TEAS treatment included head acupoint Baihui(DU20), abdominal acupoint Zhongji (RN3), Guanyuan (RN4), Zigong(EX-CA1), leg acupoint Sanyinjiao(SP6), waist acupoint Shenyu (BL23) and Guanyuanyu(BL26). Patients in no intervention group will not be given any intervention for 12 weeks prior to COS. When at least one dominant follicle is greater than 18 mm then injection a GnRH agonist (Triptorelin, Ferring, Switzerland) 0.2mg. 36 hours later transvaginal oocyte retrieval will be taken. After 3 hours of incubation, each egg will be transferred with a density of about 100,000/mllive sperm. The fresh embryo transfer is performed 72 hours after embryo culture in vitro. The whole embryos will be frozen.
The primary outcome measure is the number of MII eggs obtained in the COS cycle. The secondary outcome measures are the lab and clinical reproductive outcomes,including basic endocrine, serum Anti-Mullerian Hormone (AMH), antral follicle counts, fertilization rate, cleavage rate, number of D3 embryos, the clinical pregnancy rate and early abortion rate.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 92
- The poor ovarian response patients compliance with Bologna consensus
- Age:20-45 year
- Women undergoing IVF-ET because of infertility for more than one year.
- Patients with genital tract malformation. Uterine malformation (single uterus, double uterus, double uterus, untreated mediastinal uterus) and other effects affecting uterine cavity disease (adenomyosis, submucosal uterine fibroids, intrauterine adhesions and scar uterus)
- Complicated with other medical diseases(Hypertension, diabetes, psychosis, hereditary diseases)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description the TEAS intervention group TEAS Patients in this group will be given TEAS treatment for 12 weeks prior to COS.
- Primary Outcome Measures
Name Time Method The number of MII eggs one day after oocyte pickup The number of MII eggs obtained in the COS cycle
- Secondary Outcome Measures
Name Time Method cleavage rate cleavage rate calculated on 2 days after oocyte pickup cleavage rate
Basic Follicle stimulating hormone (FSH) value On Day two of menstruation Basic FSH value in mIU/ml
the number of Day 3 embryos the number of Day 3 embryos calculated on 3 days after oocyte pickup the number of Day 3 embryos
clinical pregnancy rate clinical pregnancy rate calculated on the 6th gestational week clinical pregnancy rate
antral follicle count antral follicle count On Day two of menstruation antral follicle count
fertilization rate fertilization rate calculated on 1 day after oocyte pickup fertilization rate
early abortion rate early abortion rate calculated on 12th week of pregnancy early abortion rate
Basic estrodiol value On Day two of menstruation Basic estrodiol in pg/ml
Serum AMH value On Day two of menstruation Serum AMH in ng/ml
Basic Luteinizing hormone (LH) value On Day two of menstruation Basic LH in mIU/ml
Trial Locations
- Locations (1)
Shanghai Ji Ai Genetics & IVF Institute, Obstetrics and Gynecology Hospital of Fudan University
🇨🇳Shanghai, Shanghai, China